MEK1/2 kinases cooperate with c-Myc:MAX to prevent polycomb repression ofTERTin human pluripotent stem cells

Abstract

Telomerase counteracts telomere shortening, enabling human embryonic stem cells (hESC) to undergo long-term proliferation. MAPK signaling plays a major role in regulating the self-renewal of hESC, and previous studies in induced pluripotent stem cells (iPSC) suggested that expression ofTERT, the gene encoding the catalytic subunit of telomerase, relies on MAPK signaling. We examined whether MEK-ERK signaling regulatedTERTtranscription in a model of normal hESC. Kinase inhibitors of MEK1 and MEK2 (MEKi) or ERK1 and ERK2 (ERKi) significantly repressedTERTmRNA levels. Using chromatin immunoprecipitation (ChIP) we observed that MEKi induced the accumulation of the repressive histone mark histone 3 lysine 27 trimethylation (H3K27me3) at theTERTproximal promoter. This increase corresponded with a loss of histone 3 lysine 27 acetylation (H3K27ac) which is associated with transcriptionally active loci. Inhibition of the polycomb repressive complex 2 (PRC2), which deposits H3K27me3, partially rescued the loss ofTERTexpression, indicating that MEK1/2 activity can limit PRC2 activity atTERT. Inhibition of MEK/ERK kinases also repressed expression of c-Myc, a transcription factor reported to regulateTERTin other immortalized cells. Consistent with a key role for c-Myc in regulatingTERT, low doses of a c-Myc:MAX dimerization inhibitor induced a striking and rapid gain of H3K27me3 atTERTand repressedTERTtranscription in hESC. Inhibiting c-Myc:MAX dimerization also resulted in lower MAX recruitment toTERT, suggesting that this complex acts in cis atTERT. Our study using a model of normal human pluripotent stem cells identifies new regulators and mechanisms controlling transcription of an important, developmentally regulated gene involved in telomere protection.